MS
MARC SCHLOSS
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · WASHINGTON, DC · registered since 2024
Registered · LDAActive
At a glance
Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
4
6 agencies contacted
Activity
filings by quarter
Works on
Specific issues
H.R. 4794 - Dietary Supplement Access Act H.R. 8599 - Oral Care Products Inclusion Act
H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023 Office of the US Trade Representative 2024 Review of Notorious Markets for Counterfeiting and Piracy: Comment Request; Request for comments
Lobbying activities related to children's pain relieving medicines and supply chain. H.R. 3008 - Drug Shortage Prevention Act of 2023 Issues related to pharmaceutical tariffs
OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee Drug Enforcement Administration Pseudoephedrine quotas
S.150 - Affordable Prescriptions for Patients Act of 2023 Pandemic and All Hazards Preparedness Act Reauthorization Over-the-Counter access to oral contraception FDA Modernization Act 3.0 Dietary Supplement Listing Act Reauthorization of the Over the Counter Monograph User Fee Act (OMUFA) Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act S.5243 - Cannabinoid Safety and Regulation Act
Lobbying activities related to children's pain relieving medicines and supply chain. H.R. 3008 - Drug Shortage Prevention Act of 2023